Skip to main content
SpringerLink
Log in

Healthcare-associated infections in long-term care facilities (HALT)

Ergebnisse aus Deutschland im Rahmen einer europäischen Prävalenzstudie

Healthcare-associated infections in long-term care facilities

German results of the European prevalence study HALT

  • Originalien und Übersichten
  • Published:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Aims and scope

Zusammenfassung

Die Ursachen für die Entstehung von Infektionen bei alten Menschen, die in Heimen leben, sind vielfältig. Die oftmals daraus resultierende Antibiotikatherapie kann zudem zu einer Selektion multiresistenter Erreger führen und damit ein zusätzliches Risiko darstellen. Für Deutschland und die meisten europäischen Länder existieren nur einige wenige Prävalenzstudien zu sogenannten healthcare associated infections (HCAI) in Altenpflegeheimen, und eine fortlaufende Dokumentation und Bewertung von HCAI und Antibiotikagaben in Altenpflegeheimen ist nicht etabliert. Daher wurde die europäische Prävalenzstudie HALT (healthcare associated infections in long-term care) entwickelt, die als Ziel hatte, sowohl HCAI als auch den Antibiotikagebrauch und die Antibiotikaresistenz von Erregern in Altenpflegeheimen zu erfassen. Insgesamt haben 73 Einrichtungen aus Deutschland am HALT-Projekt teilgenommen. Die HCAI-Prävalenz für eine wahrscheinliche Infektion (mindestens ein Symptom) lag bei 1,6 (CI 1,09–2,03), für eine gesicherte Infektion gemäß der modifizierten McGeer-Kriterien bei 0,79 (CI 0,62–1,04). Insgesamt wurde eine Antibiotikaprävalenz von 1,15 (CI 0,73–1,57) erfasst. Im vorliegenden Beitrag werden die für Deutschland erhobenen Daten aus dem HALT-Projekt vorgestellt.

Abstract

The development of infections in elderly people living in long-term care facilities may have manifold causes. Infections are often treated with an antibiotic which can trigger the selection of multirestistant microorganisms and, therefore, represents an additional risk factor. In Germany as well as in other European countries, only a few prevalence studies on healthcare-associated infections (HCAI) in long-term care facilities have been performed and there is no continuous surveillance established for HCAI and antibiotic treatment. Therefore, the European prevalence study HALT (healthcare-associated infections in long-term care) was initiated to collect data of HCAI, antibiotic use, and the antibiotic resistance of microorganisms in long-term care facilities. From Germany, 73 institutions participated in the HALT project. The overall prevalence for an optional HCAI (at least one symptom) was 1.6 (CI 1.09–2.03) and for HCAI identified by the modified McGeer criteria 0.79 (CI 0.62–1.04). The overall prevalence for antibiotic use was 1.15 (CI 0.73–1.57). In the present paper, the German results of the HALT project are presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Jackson MM, Fierer J (1985) Infections and infection risk in residents of long-term care facilities: a review of the literature, 1970–1984. Am J Infect Control 13:63–77

    Article  PubMed  CAS  Google Scholar 

  2. Garibaldi RA, Brodine S, Matsumiya S (1981) Infections among patients in nursing homes: policies, prevalence, problems. N Engl J Med 305:731–735

    Article  PubMed  CAS  Google Scholar 

  3. Koch AM, Eriksen HM, Elstrom P et al (2009) Severe consequences of healthcare-associated infections among residents of nursing homes: a cohort study. J Hosp Infect 71:269–274

    Article  PubMed  CAS  Google Scholar 

  4. Strausbaugh LJ, Joseph CL (2000) The burden of infection in long-term care. Infect Control Hosp Epidemiol 21:674–679

    Article  PubMed  CAS  Google Scholar 

  5. Beck-Sague C, Villarino E, Giuliano D et al (1994) Infectious diseases and death among nursing home residents: results of surveillance in 13 nursing homes. Infect Control Hosp Epidemiol 15:494–496

    Article  PubMed  CAS  Google Scholar 

  6. Rieg S, Peyerl-Hoffmann G, With K de et al (2009) Mortality of S. aureus bacteremia and infectious diseases specialist consultation – a study of 521 patients in Germany. J Infect 59:232–239

    Article  PubMed  Google Scholar 

  7. Beeston CJ, Gupta R, Chadwick PR, Young RJ (2009) Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital. Eur J Clin Microbiol Infect Dis 28:585–590

    Article  PubMed  CAS  Google Scholar 

  8. Malani PN, Rana MM, Banerjee M, Bradley SF (2008) Staphylococcus aureus bloodstream infections: the association between age and mortality and functional status. J Am Geriatr Soc 56:1485–1489

    Article  PubMed  Google Scholar 

  9. Datta R, Huang SS (2008) Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 47:176–181

    Article  PubMed  Google Scholar 

  10. Infektionsschutzgesetz (2000) Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen – Infektionsschutzgesetz-. Bundesgesetzblatt I 33:1045–1077

    Google Scholar 

  11. Engelhart S, Lauer A, Simon A et al (2009) Repeated prevalence investigations of nursing home-associated infections as a tool to assess the hygienic quality of care. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 52:936–944

    Article  CAS  Google Scholar 

  12. Moro ML, Mongardi M, Marchi M et al (2007) Prevalence of long-term care acquired infections in nursing and residential homes in the Emilia-Romagna region. Infection 35:250–255

    Article  PubMed  CAS  Google Scholar 

  13. Eriksen HM, Iversen BG, Aavitsland P (2004) Prevalence of nosocomial infections and use of antibiotics in long-term care facilities in Norway, 2002 and 2003. J Hosp Infect 57:316–320

    Article  PubMed  CAS  Google Scholar 

  14. Serrano Godoy M, Barcenilla F, Toribio F et al (2003) Registro de infección sociosanitaria-Lleida (RISS-Lleida): Estudio multicéntrico de la infección nosocomial en los centros sociosanitarios de la Regió Sanitària Lleida. Primera fase del estudio RISS Lleida. Rev Mult Gerontol 13(1):7–14

    Google Scholar 

  15. Blix HS, Bergman J, Schjott J (2010) How are antibacterials used in nursing homes? Results from a point-prevalence prescription study in 44 Norwegian nursing homes. Pharmacoepidemiol Drug Saf 19:1025–1030

    Article  PubMed  Google Scholar 

  16. European Surveillance of Antimicrobial Consumption [web site]. http://www.esac.ua.ac.be

  17. McGeer A, Campbell B, Emori TG et al (1991) Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 19(1):1–7

    Article  PubMed  CAS  Google Scholar 

  18. Stevenson KB, Moore J, Colwell H, Sleeper B (2005) Standardized infection surveillance in long-term care: interfacility comparisons from a regional cohort of facilities. Infect Control Hosp Epidemiol 26:231–238

    Article  PubMed  Google Scholar 

  19. Lee YL, Thrupp LD, Lee R et al (1996) Infection surveillance and antibiotic utilization in a community-based skilled nursing facility. Aging (Milano) 8:113–122

    Google Scholar 

  20. Nicolle LE, Strausbaugh LJ, Garibaldi RA (1996) Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev 9:1–17

    PubMed  CAS  Google Scholar 

  21. Tsan L, Davis C, Langberg R et al (2008) Prevalence of nursing home-associated infections in the Department of Veterans Affairs nursing home care units. Am J Infect Control 36:173–179

    Article  PubMed  Google Scholar 

  22. Engelhart ST, Hanses-Derendorf L, Exner M, Kramer MH (2005) Prospective surveillance for healthcare-associated infections in German nursing home residents. J Hosp Infect 60:46–50

    Article  PubMed  CAS  Google Scholar 

  23. Heudorf U, Schulte D (2009) Surveillance of nosocomial infections in a long-term care facility. Incidence and risk factors. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 52:732–743

    Article  CAS  Google Scholar 

  24. Muller A, Mauny F, Talon D et al (2006) Effect of individual- and group-level antibioic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother 58(4):878–881

    Article  PubMed  CAS  Google Scholar 

Download references

Danksagung

Wir danken allen beteiligten Gesundheitsämtern und Einrichtungen für ihre Teilnahme und ihr Engagement. Ohne sie wäre diese Studie nicht möglich gewesen.

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Gesundheitsamt Charlottenburg-Wilmersdorf, 10715, Berlin, Deutschland

    N. Wischnewski

  2. Robert Koch Institut, Berlin, Deutschland

    M. Mielke

  3. MVZ Labor Limbach, Heidelberg, Deutschland

    C. Wendt

Authors
  1. N. Wischnewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Mielke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Wendt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Wischnewski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wischnewski, N., Mielke, M. & Wendt, C. Healthcare-associated infections in long-term care facilities (HALT). Bundesgesundheitsbl. 54, 1147–1152 (2011). https://doi.org/10.1007/s00103-011-1363-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00103-011-1363-5

Schlüsselwörter

Keywords

Search

Navigation